vs
ASP Isotopes Inc.（ASPI）与Cytosorbents Corp（CTSO）财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是Cytosorbents Corp的1.8倍（$16.7M vs $9.2M），ASP Isotopes Inc.同比增速更快（1295.7% vs 0.9%），Cytosorbents Corp自由现金流更多（$-4.9M vs $-47.4M）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
Cytosorbents是一家公开上市企业，总部位于美国新泽西州普林斯顿，专注于血液净化领域相关医疗产品的研发与商业化，核心产品应用于重症救治场景，帮助去除患者血液中的炎性介质等有害物质。
ASPI vs CTSO — 直观对比
营收规模更大
ASPI
是对方的1.8倍
$9.2M
营收增速更快
ASPI
高出1294.8%
0.9%
自由现金流更多
CTSO
多$42.5M
$-47.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $9.2M |
| 净利润 | — | $-5.5M |
| 毛利率 | 12.5% | 73.7% |
| 营业利润率 | — | -47.5% |
| 净利率 | — | -59.5% |
| 营收同比 | 1295.7% | 0.9% |
| 净利润同比 | -586.8% | 27.4% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPICTSO
| Q4 25 | $16.7M | $9.2M | ||
| Q3 25 | $4.9M | $9.5M | ||
| Q2 25 | — | $9.6M | ||
| Q1 25 | — | $8.7M | ||
| Q4 24 | — | $9.2M | ||
| Q3 24 | — | $8.6M | ||
| Q2 24 | — | $8.8M | ||
| Q1 24 | — | $9.0M |
净利润ASPICTSO
| Q4 25 | — | $-5.5M | ||
| Q3 25 | $-12.9M | $-3.2M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $-1.5M | ||
| Q4 24 | — | $-7.6M | ||
| Q3 24 | — | $-2.8M | ||
| Q2 24 | — | $-4.3M | ||
| Q1 24 | — | $-6.1M |
毛利率ASPICTSO
| Q4 25 | 12.5% | 73.7% | ||
| Q3 25 | 8.7% | 70.3% | ||
| Q2 25 | — | 70.9% | ||
| Q1 25 | — | 71.1% | ||
| Q4 24 | — | 68.4% | ||
| Q3 24 | — | 61.0% | ||
| Q2 24 | — | 73.5% | ||
| Q1 24 | — | 76.5% |
营业利润率ASPICTSO
| Q4 25 | — | -47.5% | ||
| Q3 25 | -306.1% | -30.2% | ||
| Q2 25 | — | -37.6% | ||
| Q1 25 | — | -44.5% | ||
| Q4 24 | — | -37.1% | ||
| Q3 24 | — | -56.1% | ||
| Q2 24 | — | -40.4% | ||
| Q1 24 | — | -51.8% |
净利率ASPICTSO
| Q4 25 | — | -59.5% | ||
| Q3 25 | -263.7% | -33.4% | ||
| Q2 25 | — | 20.2% | ||
| Q1 25 | — | -16.9% | ||
| Q4 24 | — | -82.7% | ||
| Q3 24 | — | -32.1% | ||
| Q2 24 | — | -48.6% | ||
| Q1 24 | — | -67.7% |
每股收益（稀释后）ASPICTSO
| Q4 25 | — | $-0.09 | ||
| Q3 25 | $-0.15 | $-0.05 | ||
| Q2 25 | — | $0.03 | ||
| Q1 25 | — | $-0.02 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | — | $-0.05 | ||
| Q2 24 | — | $-0.08 | ||
| Q1 24 | — | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $6.2M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $5.9M |
| 总资产 | $498.0M | $44.2M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资ASPICTSO
| Q4 25 | $333.3M | $6.2M | ||
| Q3 25 | $113.9M | $7.5M | ||
| Q2 25 | — | $10.2M | ||
| Q1 25 | — | $11.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | $8.5M | ||
| Q1 24 | — | $8.6M |
总债务ASPICTSO
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $13.8M | ||
| Q2 24 | — | $13.7M | ||
| Q1 24 | — | $4.4M |
股东权益ASPICTSO
| Q4 25 | $204.2M | $5.9M | ||
| Q3 25 | $74.1M | $9.0M | ||
| Q2 25 | — | $11.6M | ||
| Q1 25 | — | $14.5M | ||
| Q4 24 | — | $11.1M | ||
| Q3 24 | — | $13.4M | ||
| Q2 24 | — | $17.4M | ||
| Q1 24 | — | $19.6M |
总资产ASPICTSO
| Q4 25 | $498.0M | $44.2M | ||
| Q3 25 | $225.9M | $45.8M | ||
| Q2 25 | — | $48.0M | ||
| Q1 25 | — | $50.8M | ||
| Q4 24 | — | $47.4M | ||
| Q3 24 | — | $47.8M | ||
| Q2 24 | — | $53.4M | ||
| Q1 24 | — | $47.1M |
负债/权益比ASPICTSO
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $-4.8M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | $-4.9M |
| 自由现金流率自由现金流/营收 | -284.7% | -53.4% |
| 资本支出强度资本支出/营收 | 57.9% | 1.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-12.5M |
8季度趋势，按日历期对齐
经营现金流ASPICTSO
| Q4 25 | $-37.8M | $-4.8M | ||
| Q3 25 | $-8.9M | $-2.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $-2.3M | ||
| Q3 24 | — | $-2.5M | ||
| Q2 24 | — | $-4.8M | ||
| Q1 24 | — | $-4.8M |
自由现金流ASPICTSO
| Q4 25 | $-47.4M | $-4.9M | ||
| Q3 25 | $-12.0M | $-2.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $-2.4M | ||
| Q3 24 | — | $-2.6M | ||
| Q2 24 | — | $-4.8M | ||
| Q1 24 | — | $-4.9M |
自由现金流率ASPICTSO
| Q4 25 | -284.7% | -53.4% | ||
| Q3 25 | -245.5% | -27.3% | ||
| Q2 25 | — | -16.1% | ||
| Q1 25 | — | -39.7% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -30.4% | ||
| Q2 24 | — | -54.4% | ||
| Q1 24 | — | -54.2% |
资本支出强度ASPICTSO
| Q4 25 | 57.9% | 1.2% | ||
| Q3 25 | 64.4% | 0.2% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.5% |
现金转化率ASPICTSO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.78× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPI
暂无分部数据
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
